• Home
  • Pharmaceuticals and Healthcare
Fabry Disease Treatment Market, Global Outlook and Forecast 2023-2029

Fabry Disease Treatment Market, Global Outlook and Forecast 2023-2029

Report Code: KNJ1552793 | No. of Pages: 65 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Feb-2023 
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
This report aims to provide a comprehensive presentation of the global market for Fabry Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fabry Disease Treatment. This report contains market size and forecasts of Fabry Disease Treatment in global, including the following market information:
Global Fabry Disease Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Fabry Disease Treatment market was valued at US$ 1576.6 million in 2022 and is projected to reach US$ 2243.3 million by 2029, at a CAGR of 5.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Enzyme Replacement Therapy (ERT) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fabry Disease Treatment include Sanofi S.A., Takeda, Amicus Therapeutics Inc., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc. and Greenovation Biotech GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fabry Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fabry Disease Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fabry Disease Treatment Market Segment Percentages, by Type, 2022 (%)
    Enzyme Replacement Therapy (ERT)
    Chaperone Treatment
    Substrate Reduction Therapy (SRT)
    Others
Global Fabry Disease Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fabry Disease Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinic
    Others
Global Fabry Disease Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fabry Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fabry Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fabry Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi S.A.
    Takeda
    Amicus Therapeutics Inc.
    ISU Abxis Co Ltd.
    JCR Pharmaceuticals Co Ltd.
    Protalix Biotherapeutics Inc.
    Idorsia Pharmaceuticals Ltd.
    Avrobio Inc.
    Greenovation Biotech GmbH
    Moderna Therapeutics Inc.
    Green Cross Pharma Pte Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fabry Disease Treatment, market overview.
Chapter 2: Global Fabry Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of Fabry Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fabry Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
    1.1 Fabry Disease Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Fabry Disease Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Fabry Disease Treatment Overall Market Size
    2.1 Global Fabry Disease Treatment Market Size: 2022 VS 2029
    2.2 Global Fabry Disease Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Fabry Disease Treatment Players in Global Market
    3.2 Top Global Fabry Disease Treatment Companies Ranked by Revenue
    3.3 Global Fabry Disease Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Fabry Disease Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Fabry Disease Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Fabry Disease Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Fabry Disease Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Fabry Disease Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Fabry Disease Treatment Market Size Markets, 2022 & 2029
        4.1.2 Enzyme Replacement Therapy (ERT)
        4.1.3 Chaperone Treatment
        4.1.4 Substrate Reduction Therapy (SRT)
        4.1.5 Others
    4.2 By Type - Global Fabry Disease Treatment Revenue & Forecasts
        4.2.1 By Type - Global Fabry Disease Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Fabry Disease Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Fabry Disease Treatment Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Fabry Disease Treatment Revenue & Forecasts
        5.2.1 By Application - Global Fabry Disease Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Fabry Disease Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Fabry Disease Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Fabry Disease Treatment Revenue & Forecasts
        6.2.1 By Region - Global Fabry Disease Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Fabry Disease Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Fabry Disease Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Fabry Disease Treatment Revenue, 2018-2029
        6.3.2 US Fabry Disease Treatment Market Size, 2018-2029
        6.3.3 Canada Fabry Disease Treatment Market Size, 2018-2029
        6.3.4 Mexico Fabry Disease Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Fabry Disease Treatment Revenue, 2018-2029
        6.4.2 Germany Fabry Disease Treatment Market Size, 2018-2029
        6.4.3 France Fabry Disease Treatment Market Size, 2018-2029
        6.4.4 U.K. Fabry Disease Treatment Market Size, 2018-2029
        6.4.5 Italy Fabry Disease Treatment Market Size, 2018-2029
        6.4.6 Russia Fabry Disease Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Fabry Disease Treatment Market Size, 2018-2029
        6.4.8 Benelux Fabry Disease Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Fabry Disease Treatment Revenue, 2018-2029
        6.5.2 China Fabry Disease Treatment Market Size, 2018-2029
        6.5.3 Japan Fabry Disease Treatment Market Size, 2018-2029
        6.5.4 South Korea Fabry Disease Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Fabry Disease Treatment Market Size, 2018-2029
        6.5.6 India Fabry Disease Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Fabry Disease Treatment Revenue, 2018-2029
        6.6.2 Brazil Fabry Disease Treatment Market Size, 2018-2029
        6.6.3 Argentina Fabry Disease Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Fabry Disease Treatment Revenue, 2018-2029
        6.7.2 Turkey Fabry Disease Treatment Market Size, 2018-2029
        6.7.3 Israel Fabry Disease Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Fabry Disease Treatment Market Size, 2018-2029
        6.7.5 UAE Fabry Disease Treatment Market Size, 2018-2029
7 Fabry Disease Treatment Companies Profiles
    7.1 Sanofi S.A.
        7.1.1 Sanofi S.A. Company Summary
        7.1.2 Sanofi S.A. Business Overview
        7.1.3 Sanofi S.A. Fabry Disease Treatment Major Product Offerings
        7.1.4 Sanofi S.A. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.1.5 Sanofi S.A. Key News & Latest Developments
    7.2 Takeda
        7.2.1 Takeda Company Summary
        7.2.2 Takeda Business Overview
        7.2.3 Takeda Fabry Disease Treatment Major Product Offerings
        7.2.4 Takeda Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.2.5 Takeda Key News & Latest Developments
    7.3 Amicus Therapeutics Inc.
        7.3.1 Amicus Therapeutics Inc. Company Summary
        7.3.2 Amicus Therapeutics Inc. Business Overview
        7.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
        7.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.3.5 Amicus Therapeutics Inc. Key News & Latest Developments
    7.4 ISU Abxis Co Ltd.
        7.4.1 ISU Abxis Co Ltd. Company Summary
        7.4.2 ISU Abxis Co Ltd. Business Overview
        7.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Major Product Offerings
        7.4.4 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.4.5 ISU Abxis Co Ltd. Key News & Latest Developments
    7.5 JCR Pharmaceuticals Co Ltd.
        7.5.1 JCR Pharmaceuticals Co Ltd. Company Summary
        7.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
        7.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Major Product Offerings
        7.5.4 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.5.5 JCR Pharmaceuticals Co Ltd. Key News & Latest Developments
    7.6 Protalix Biotherapeutics Inc.
        7.6.1 Protalix Biotherapeutics Inc. Company Summary
        7.6.2 Protalix Biotherapeutics Inc. Business Overview
        7.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Major Product Offerings
        7.6.4 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.6.5 Protalix Biotherapeutics Inc. Key News & Latest Developments
    7.7 Idorsia Pharmaceuticals Ltd.
        7.7.1 Idorsia Pharmaceuticals Ltd. Company Summary
        7.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
        7.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Major Product Offerings
        7.7.4 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.7.5 Idorsia Pharmaceuticals Ltd. Key News & Latest Developments
    7.8 Avrobio Inc.
        7.8.1 Avrobio Inc. Company Summary
        7.8.2 Avrobio Inc. Business Overview
        7.8.3 Avrobio Inc. Fabry Disease Treatment Major Product Offerings
        7.8.4 Avrobio Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.8.5 Avrobio Inc. Key News & Latest Developments
    7.9 Greenovation Biotech GmbH
        7.9.1 Greenovation Biotech GmbH Company Summary
        7.9.2 Greenovation Biotech GmbH Business Overview
        7.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Major Product Offerings
        7.9.4 Greenovation Biotech GmbH Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.9.5 Greenovation Biotech GmbH Key News & Latest Developments
    7.10 Moderna Therapeutics Inc.
        7.10.1 Moderna Therapeutics Inc. Company Summary
        7.10.2 Moderna Therapeutics Inc. Business Overview
        7.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
        7.10.4 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.10.5 Moderna Therapeutics Inc. Key News & Latest Developments
    7.11 Green Cross Pharma Pte Ltd.
        7.11.1 Green Cross Pharma Pte Ltd. Company Summary
        7.11.2 Green Cross Pharma Pte Ltd. Business Overview
        7.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Major Product Offerings
        7.11.4 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue in Global Market (2018-2023)
        7.11.5 Green Cross Pharma Pte Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com